Low serum albumin level is associated with cytomegalovirus reactivation in patients with chronic lymphoproliferative diseases treated with alemtuzumab (campath-1H)-based therapies
Gautam Borthakur, E. Lin, Stefan Faderl, Alessandra Ferrajoli, William Wierda, Francis Giles, Mary L. Browning, Hagop Kantarjian, Michael Keating, Susan O'Brien*
Dive into the research topics of 'Low serum albumin level is associated with cytomegalovirus reactivation in patients with chronic lymphoproliferative diseases treated with alemtuzumab (campath-1H)-based therapies'. Together they form a unique fingerprint.